Gerstenecker Stefan, Haarer Lisa, Schröder Martin, Kudolo Mark, Schwalm Martin P, Wydra Valentin, Serafim Ricardo A M, Chaikuad Apirat, Knapp Stefan, Laufer Stefan, Gehringer Matthias
Department of Pharmaceutical/Medicinal Chemistry, Institute of Pharmaceutical Sciences, Eberhard Karls University Tübingen, 72076 Tübingen, Germany.
Department of Biochemistry, Chemistry and Pharmacy, Institute for Pharmaceutical Chemistry, Goethe University Frankfurt, 60438 Frankfurt, Germany.
Cancers (Basel). 2021 Oct 13;13(20):5133. doi: 10.3390/cancers13205133.
The ribosomal protein S6 kinase beta 2 (S6K2) is thought to play an important role in malignant cell proliferation, but is understudied compared to its closely related homolog S6 kinase beta 1 (S6K1). To better understand the biological function of S6K2, chemical probes are needed, but the high similarity between S6K2 and S6K1 makes it challenging to selectively address S6K2 with small molecules. We were able to design the first potent and highly isoform-specific S6K2 inhibitor from a known S6K1-selective inhibitor, which was merged with a covalent inhibitor engaging a cysteine located in the hinge region in the fibroblast growth factor receptor kinase (FGFR) 4 via a nucleophilic aromatic substitution (SAr) reaction. The title compound shows a high selectivity over kinases with an equivalently positioned cysteine, as well as in a larger kinase panel. A good stability towards glutathione and α-acetyl lysine indicates a non-promiscuous reactivity pattern. Thus, the title compound represents an important step towards a high-quality chemical probe to study S6K2-specific signaling.
核糖体蛋白S6激酶β2(S6K2)被认为在恶性细胞增殖中起重要作用,但与其密切相关的同源物S6激酶β1(S6K1)相比,对其研究较少。为了更好地理解S6K2的生物学功能,需要化学探针,但S6K2和S6K1之间的高度相似性使得用小分子选择性靶向S6K2具有挑战性。我们能够从一种已知的S6K1选择性抑制剂设计出第一种强效且高度亚型特异性的S6K2抑制剂,该抑制剂通过亲核芳香取代(SAr)反应与一种共价抑制剂结合,该共价抑制剂与成纤维细胞生长因子受体激酶(FGFR)4铰链区的一个半胱氨酸结合。标题化合物对具有等效位置半胱氨酸的激酶以及更大的激酶组显示出高选择性。对谷胱甘肽和α-乙酰赖氨酸具有良好的稳定性,表明其反应模式不具有混杂性。因此,标题化合物代表了朝着研究S6K2特异性信号传导的高质量化学探针迈出的重要一步。